Agammaglobulinemia News and Articles

Return to Library

Recent Agammaglobulinemia News and Articles

• \"Cd40 Antibody Formulation and Methods\" in Patent Application Approval Process
• Investigators at Yale University Discuss Research in Rheumatoid Arthritis
• Patent Issued for Inhibitors of Bruton\'S Tyrosine Kinase
• Researchers Submit Patent Application, \"Protein a Compositions and Methods of Use\", for Approval
• Data from Korea University Medical Center Advance Knowledge in Medical Science
• Research from Karolinska University Hospital in the Area of Agammaglobulinemia Described
• Patent Issued for Protein KTPAF50
• New Findings from Kumamoto University in the Area of Genetics and Agammaglobulinemia Described
• Patent Issued for Anti-HIMF Antibodies to Treat Lung Diseases

---

Researchers from Babol University of Medical Sciences Report on Findings in Genetics and Encephalitis

2012 NOV 2 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Data detailed on Virus Diseases have been presented. According to news reporting originating from Babol, Iran, by NewsRx correspondents, research stated, "X-linked agammaglobulinemia (XLA), also known as Bruton's tyrosine kinase (BTK) deficiency, is a primary antibody deficiency, characterized by low number of B cells, agammaglobulinemia and increased susceptibility to a variety of infections. Herein, we report a case of XLA with confirmed BTK mutation that developed neurological deficits."

Our news editors obtained a quote from the research from the Babol University of Medical Sciences, "While we could not detect any responsible microorganism in spite of comprehensive workup, brain magnetic resonance imaging revealed moderate brain atrophy. The diagnosis of progressive encephalitis was made for this patient. Patients with XLA have a higher chance of encephalitis compared with other primary antibody deficiencies."

According to the news editors, the research concluded: "Given the violent nature of encephalitis, it is a concern among XLA patients."

For more information on this research see: Debilitating progressive encephalitis in a patient with BTK deficiency. Acta Microbiologica Et Immunologica Hungarica, 2012;59(3):335-42.

The news editors report that additional information may be obtained by contacting I. Mohammadzadeh, Babol University of Medical Sciences, Non-Communicable Pediatric Diseases Research Center, Babol, Iran.

Keywords for this news article include: Iran, Asia, Babol, Genetics, Encephalitis, Virus Diseases, Central Nervous System Diseases.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2012, NewsRx LLC